Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sinecatechins is a topical botanical drug derived from the partially purified water extract of green tea leaves (Camellia sinensis). It consists primarily of catechins (85–95% by weight), with epigallocatechin gallate (EGCg) as the major component. Sinecatechins is used for the treatment of external genital and perianal warts (condylomata acuminata) in immunocompetent adults. Its mechanism of action is not fully understood but is believed to involve antiviral activity against human papillomavirus (HPV), antioxidant effects, and possible immune system activation at the site of application. Sinecatechins does not cure HPV infection or prevent future wart outbreaks[1][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sinecatechins.